Esophagram - Volume 9 / Issue 8

Volume 9, Issue 8 - August 2022

ISDE 2022 Is One Month Away!

The 18^th Annual ISDE World Congress is just around the corner and we are thrilled to introduce our speakers who will share with us their knowledge, insights and experience in esophageal diseases!

Don't miss the opportunity to learn from global speakers and find solutions to the challenges that are impacting the esophageal community.

ISDE 2022 features the most impressive line up of speakers in the field with expert speakers from Japan, Europe, North America and around the globe. We invite you to read their bios and learn more about their background, education, and success!

Meet the Speakers

A Multidisciplinary Congress For Everyone

There is something for everyone in this year’s program: from the latest in targeted therapies to the cutting edge in Barret's Esophagus supplemented with a spectacular array of surgical techniques, discussions and insights on the rapidly moving landscape of esophageal cancer treatments, just to name a few. ISDE 2022 is truly a multidisciplinary congress.

Some of the many reasons why you should be there:

Attended by global experts and colleagues in the field of Esophageal Cancer and Gastroenterology
Delivering 5 streams of concurrent content on each of the 3 congress days
Live stream scheduled to commence at different times each day
Something of interest for all disciplines at a convenient time each day
Catch all sessions with both live and on-demand access

Don't miss out! The ISDE 2022 congress team invites you to learn, share knowledge, and network with international delegates from across the globe at the 18^th annual ISDE World Congress taking place virtually from September 26 to 28, 2022.

Check the World Congress webpage for updates or join the mailing list

Interactive Young ISDE Session at Congress - A Must See!

Join the launch of the Young ISDE Committee at this year's ISDE Congress for a compelling and vibrant "Meet the Professors" session organized by Sheraz Markar (Oxford University Hospital, NHS Trust), Jessie Elliott (Royal College of Surgeons in Ireland) and David Liu (Austin Hospital). You'll hear insightful presentations followed by a live, interactive question and answer period:

Developing Esophageal Clinical Trials in 2022 - David Watson
Building a Career in Translational Research - Sheila Krishnadath
Creating the Next Generation of Allied Health Professional Researchers - Emer Guinan
Establishing International Research Collaboratives - Ewen Griffiths

To receive more information about the Young ISDE, sign up here.

For more information about the program, click here.

Why Become an ISDE Congress Supporter?

It's never too late to receive valuable exposure that occurs before, during and after the ISDE Congress. With over 500+ expected attendees, this event spans the entire globe and includes participation from a diverse group of gastroenterologists, oncologists, radiologists, surgeons, pathologists and many others!

A wide variety of exposure opportunities are available to meet every budget including keynote lectures, plenary sessions, video sessions, featured abstracts, banner ads and much more!

Become a Platinum, Diamond, Gold, Silver, Bronze or Congress Supporter today! Contact the ISDE 2022 Sponsorship & Exhibit Manager here.

Thank You to Our Current Diamond and Silver Sponsors!

View More Sponsors & Info Here

DOTE - Volume 35, Issue 8, August 2022

The latest issue of Diseases of the Esophagus Journal is now available online.

Subscribe to content alerts.

Transthoracic Esophagectomy compared to Transhiatal Extended Gastrectomy for Adenocarcinoma of the Esophagogastric Junction: A Multicenter Retrospective Cohort Study

Editor's Choice

Original Article

The discussion about the most appropriate surgical treatment for Siewert type II adenocarcinoma of the esophagogastric junction is not new, but it is essential to seek more and more evidence to support important decision-making in choosing the surgical access for this procedure.

The aim of this study was to compare transhiatal extended gastrectomy (TEG) and transthoracic esophagectomy (TTE). Patients with Siewert type II tumors who underwent a resection by TEG or TTE in two centers between 2014 and 2019.

After matching, TEG was still associated with an increased risk of incomplete tumor resection (P = 0.03) and proximal margin involvement (P < 0.01), while there were no differences in post-operative morbidity (P = 0.56) and mortality (P = 0.31).

Click below and see the authors' recommendations on these findings.

Twitter Poll Questions Yield Interesting Results

As mentioned previously, the ISDE Communications Committee has been working hard to develop Twitter poll questions to help generate awareness about the ISDE 2022 Congress and to engage the ISDE community in conversation and exchange on social media. Take a look at the ISDE Twitter account here (or snapshots below) and see the responses to some very interesting and sometimes controversial questions!